Helixgate https://validator.w3.org/feed/docs/rss2.html Boehringer forges $7bn alliance with China’s SBP Group UK biotechs T-Therapeutics and Alethio score big financings Bayer’s Hyrnuo moves first-line for lung cancer in China Linking kinase inhibitors for greater selectivity Checkpoint inhibitor combinations: the trial-to-approval gap Degraders take on GPCRs Pritam International Private Limited – 738079 – 10/27/2026 Opioid Overdose Reversal Medications Medications for Opioid Use Disorder (MOUD) Generic Competition and Drug Prices PDUFA and BsUFA Quarterly Hiring Updates FDA Pediatric Safety Communications STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug Biopharma likely to climb higher after ‘blue wave,’ analysts say Radiopharma venture money moves toward alpha emitters FDA needs a roadmap for disease-agnostic drug development — a Perspective Caspian: Regenerating beta cells with a menin inhibitor With Vidya acquisition, Gujrathi takes chair role at Processa FDA approves first DNA plasmid immunotherapy; NME tally reaches 47 Molecular imaging reveals how shape-shifting protein complex captures DNA and holds separate sections together AlphaFold 3 predicts complex immune interactions using protein sequences alone STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more STAT+: Ultragenyx cuts staff after another study fails  STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill Standardized Apheresis Processes Would Help Cell Therapy Sector Small Bioprocess Monitoring Hits the Goldilocks Zone Rethinking the Clone-First Paradigm for First-in-Human Biologics HIV-Blocking Antibody Shows Promise, but Resistant Strains Break Through Building Custom DNA without Bacterial Constraints Gene That Preserves Bone Stem Cell Supply Throughout Life Identified As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace Multiomic Human Glioblastoma Cell Atlas Could Act as Compass to Guide Future Treatment Approaches Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites Beyond Outsourcing: Building Better CDMO Partnerships Most nurses at Ugandan hospital miss at least one of the Five Rights of antimicrobial administration, survey finds Anti-CGRP Migraine Drugs Cut Monthly Headache Days by Nearly Half in Catalan Cohort TACMONO-XL trial to test whether tacrolimus monotherapy can cut infections in older kidney transplant recipients PACE panel notes challenges IRA poses for patients Advancing Generic Drug Development: Modernizing Bioequivalence Approaches for Topical & Transdermal Products – 09/10/2026 FDA Expedited Investigational New Drug (IND) Pilot Program STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test A push for speedier drug approvals doesn’t promise smooth market sailing Advancing Generic Drug Development: Leveraging Model-Integrated Evidence (MIE) in the Development & Approval of Generic Drugs – 08/27/2026 Editor’s Pick: Wild Bioscience Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’ Amgen starts MariTide autoinjector study as pivotal readouts approach AbbVie bets up to $1.47B for Nxera’s discarded IBD program Untitled Letters Home